Holen Sie sich die Stockscreener-App
0.4794
1.24%
0.0089
Adial Pharmaceuticals Inc Aktie (ADIL) Neueste Nachrichten
Is Adial Pharmaceuticals Inc. a good long term investmentFree Capital Growth Strategies - Autocar Professional
Adial Pharmaceuticals Inc. Stock Analysis and ForecastAccelerated financial growth - Autocar Professional
What drives Adial Pharmaceuticals Inc. stock priceRemarkable growth - jammulinksnews.com
What analysts say about Adial Pharmaceuticals Inc. stockUnrivaled growth potential - Autocar Professional
Autolus Therapeutics Soars 10.79% on EU Approval of AUCATZYL - AInvest
Thermo Fisher Scientific (TMO) Inks Deal to Manufacture Adial Pharmaceuticals ADO4 - MSN
Adial Pharmaceuticals Regains Nasdaq Compliance After Offering - TipRanks
Adial Pharmaceuticals (ADIL) Regains Nasdaq Compliance | ADIL St - GuruFocus
Adial Pharmaceuticals regains Nasdaq compliance after equity offering By Investing.com - Investing.com Nigeria
Adial Pharmaceuticals regains Nasdaq compliance after equity offering - Investing.com
Adial Pharmaceuticals Regains Compliance with Nasdaq Stockholders’ Equity Listing Requirement - GlobeNewswire
Adial Pharmaceuticals Secures Future on Nasdaq: Key $2.5M Equity Requirement Achieved - Stock Titan
How Adial Pharmaceuticals Inc. stock performs during market volatilityReal Time Breakout Tracking - Newser
What makes Adial Pharmaceuticals Inc. stock price move sharplyBreakout Level Watch - Newser
Why Adial Pharmaceuticals Inc. stock attracts strong analyst attentionDaily Swing Candidates - Newser
Adial Pharmaceuticals Raises $3.6 Million to Meet Nasdaq Rules - MSN
Adial Pharmaceuticals Inc. Plunges 14.63% Amid Market Volatility - AInvest
Local Bounti (LOCL) insider files Form 144 to sell 3,500 shares - Stock Titan
Adial Pharmaceuticals (ADIL) Upgraded to Strong Buy: Here's Why - Yahoo Finance
4.79%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):